ELANCO ANIMAL HEALTH INC (ELAN) Forecast, Price Target & Analyst Ratings

NYSE:ELAN • US28414H1032

Current stock price

22.82 USD
-0.26 (-1.13%)
At close:
22.82 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELANCO ANIMAL HEALTH INC (ELAN).

Forecast Snapshot

Consensus Price Target

Price Target
$30.17
+ 32.23% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.35
Revenue Estimate
1.314B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.45%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$30.17
Upside
+ 32.23%
From current price of $22.82 to mean target of $30.17, Based on 22 analyst forecasts
Low
$24.24
Median
$30.60
High
$33.60

Price Target Revisions

1 Month
10.94%
3 Months
15.84%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for ELAN. The average price target is 30.18 USD. This implies a price increase of 32.23% is expected in the next year compared to the current price of 22.82.
The average price target has been revised upward by 15.84% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ELAN Current Analyst RatingELAN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

ELAN Historical Analyst RatingsELAN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
85.45%
ELAN was analyzed by 22 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ELAN.
In the previous month the buy percentage consensus was at a similar level.
ELAN was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-25KeybancMaintains Overweight -> Overweight
2026-02-25Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2026-02-24Leerink PartnersMaintains Outperform -> Outperform
2026-02-19JP MorganMaintains Overweight -> Overweight
2026-01-22Piper SandlerUpgrade Neutral -> Overweight
2025-12-18Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-12-09BarclaysInitiate Overweight
2025-11-21KeybancInitiate Overweight
2025-11-06UBSMaintains Buy -> Buy
2025-10-20UBSMaintains Buy -> Buy
2025-10-07JP MorganUpgrade Neutral -> Overweight
2025-09-24StifelMaintains Buy -> Buy
2025-08-11Piper SandlerMaintains Neutral -> Neutral
2025-08-08UBSMaintains Buy -> Buy
2025-07-23UBSMaintains Buy -> Buy
2025-07-17Leerink PartnersUpgrade Market Perform -> Outperform
2025-07-02StifelMaintains Buy -> Buy
2025-06-26William BlairUpgrade Market Perform -> Outperform
2025-05-19StifelMaintains Buy -> Buy
2025-05-08StifelMaintains Buy -> Buy
2025-04-14StifelMaintains Buy -> Buy
2025-03-06Piper SandlerMaintains Neutral -> Neutral
2025-02-26UBSMaintains Buy -> Buy
2025-02-26StifelMaintains Buy -> Buy
2025-02-26BarclaysMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.35
Revenue Estimate
1.314B
Revenue Q2Q
10.14%
EPS Q2Q
-4.81%
Number of Analysts
16

Next Earnings Revisions

Revenue (1 Month)
-0.15%
Revenue (3 Months)
0.61%
EPS (1 Month)
-0.14%
EPS (3 Months)
-1.48%

Next Earnings Summary

ELAN is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.35 USD and the consensus revenue estimate is 1.31B USD.
The next earnings revenue estimate has been revised upward by 0.61% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ELAN revenue by date.ELAN revenue by date.
4.417B
0.14%		4.439B
0.50%		4.715B
6.22%		5.102B
8.21%		5.372B
5.29%		5.632B
4.84%		5.853B
3.92%		6.037B
3.14%		6.206B
2.80%		6.377B
2.76%		6.428B
0.80%
EBITDA
YoY % growth
ELAN ebitda by date.ELAN ebitda by date.
1.02B
-4.32%		913M
-10.49%		932M
2.08%		1.001B
7.40%		1.092B
9.09%		1.194B
9.34%		1.266B
6.03%		1.33B
5.06%		1.389B
4.44%		1.467B
5.62%		1.454B
-0.89%
EBIT
YoY % growth
ELAN ebit by date.ELAN ebit by date.
326M
-15.10%		251M
-23.01%		252M
0.40%		802.82M
218.58%		896.26M
11.64%		998.7M
11.43%		1.105B
10.64%		1.163B
5.25%		1.217B
4.64%		1.289B
5.92%		1.262B
-2.09%
Operating Margin
ELAN operating margin by date.ELAN operating margin by date.
7.38%5.65%5.34%15.74%16.68%17.73%18.88%19.26%19.61%20.21%19.63%
EPS
YoY % growth
ELAN eps by date.ELAN eps by date.
0.89
-19.82%		0.91
2.25%		0.95
4.40%		1.05
10.73%		1.18
12.42%		1.34
13.21%		1.51
12.57%		1.54
2.20%		1.63
5.63%		1.74
6.90%		1.66
-4.40%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.35
-4.81%		0.30
14.33%		0.20
6.29%		0.20
53.84%		0.38
9.06%		0.33
12.05%		0.23
12.29%		0.22
12.43%		0.41
6.93%		0.35
5.75%		0.25
11.40%		0.28
22.48%
Revenue
Q2Q % growth		1.314B
10.14%		1.347B
8.54%		1.216B
6.95%		1.225B
7.08%		1.379B
4.95%		1.425B
5.79%		1.29B
6.09%		1.29B
5.31%		1.431B
3.77%		1.491B
4.63%		1.355B
5.04%		1.356B
5.12%
EBITDA
Q2Q % growth		306.9M
8.83%		270.47M
-34.83%		209.7M
-60.66%		208.14M
-70.22%		328.63M
7.08%		296.68M
9.69%		228.04M
8.75%		231.72M
11.33%		352.36M
7.22%		325.26M
9.63%		252.43M
10.70%		253.82M
9.54%
EBIT
Q2Q % growth		274.29M
126.69%		234.93M
176.39%		173.91M
544.11%		172.8M
809.47%		299.97M
9.36%		253.87M
8.06%		196.25M
12.85%		205.55M
18.95%		321.73M
7.25%		272.77M
7.44%		211.55M
7.80%		228.26M
11.05%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ELAN Yearly Revenue VS EstimatesELAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ELAN Yearly EPS VS EstimatesELAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.11%
EPS Next 5 Year
10.15%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.76%
Revenue Next 5 Year
4.86%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
18.81%
EBIT Next 5 Year
13.31%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELANCO ANIMAL HEALTH INC / ELAN Forecast FAQ

What is the average price target for ELANCO ANIMAL HEALTH INC (ELAN) stock?

22 analysts have analysed ELAN and the average price target is 30.18 USD. This implies a price increase of 32.23% is expected in the next year compared to the current price of 22.82.

When does ELANCO ANIMAL HEALTH INC (ELAN) report earnings?

ELANCO ANIMAL HEALTH INC (ELAN) will report earnings on 2026-05-05, before the market open.

What are the consensus estimates for ELANCO ANIMAL HEALTH INC (ELAN) next earnings?

The consensus EPS estimate for the next earnings of ELANCO ANIMAL HEALTH INC (ELAN) is 0.35 USD and the consensus revenue estimate is 1.31B USD.

How many analysts cover ELANCO ANIMAL HEALTH INC (ELAN) stock?

The number of analysts covering ELANCO ANIMAL HEALTH INC (ELAN) is 22.